These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 415501)

  • 1. Intal (sodium cromoglycate) therapy in ulcerative colitis.
    Malolepszy J; Kuczymska-Sekieta K; Chachaj W
    Acta Allergol; 1977; Suppl 13():82-6. PubMed ID: 415501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of disodium cromoglycate (Intal) on the course of ulcerative colitis].
    Szmigiel Z; Jakubowska U; Iskra S; Zawiejski A
    Pol Tyg Lek; 1979 Mar; 34(11):425-7. PubMed ID: 108670
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intal in the treatment of ulcerative colitis].
    Malolepszy J; Kuczyńska-Sekieta K; Chachaj W
    Pol Tyg Lek; 1974 Dec; 29(52):2273-4. PubMed ID: 4216889
    [No Abstract]   [Full Text] [Related]  

  • 4. Disodium cromoglycate maintenance treatment of ulcerative colitis.
    Langman MJ; Dronfield MW
    Acta Allergol; 1977; Suppl 13():76-81. PubMed ID: 24321
    [No Abstract]   [Full Text] [Related]  

  • 5. [Disodium cromoglycate (Intal) in the treatment of ulcerative colitis and the Leśniowski-Crohn disease (author's transl)].
    Szmigiel Z; Jakubowska U; Szczepaniak A; Pikor-Daraz I
    Przegl Lek; 1977; 34(9):743-6. PubMed ID: 411157
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of ulcerative colitis with oral disodium cromoglycate. A double-blind controlled trial.
    Mani V; Lloyd G; Green FH; Fox H; Turnberg LA
    Lancet; 1976 Feb; 1(7957):439-41. PubMed ID: 55715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of ulcerative colitis with DSCG.
    Mani V
    Acta Allergol; 1977; Suppl 13():69-75. PubMed ID: 415500
    [No Abstract]   [Full Text] [Related]  

  • 8. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
    Mantzaris GJ; Archavlis E; Christoforidis P; Kourtessas D; Amberiadis P; Florakis N; Petraki K; Spiliadi C; Triantafyllou G
    Am J Gastroenterol; 1997 Mar; 92(3):454-6. PubMed ID: 9068468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study.
    Paoluzi OA; Iacopini F; Pica R; Crispino P; Marcheggiano A; Consolazio A; Rivera M; Paoluzi P
    Aliment Pharmacol Ther; 2005 May; 21(9):1111-9. PubMed ID: 15854173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of disodium cromoglycate and sulphasalazine as maintenance therapy for ulcerative colitis.
    Willoughby CP; Heyworth MF; Piris J; Truelove SC
    Lancet; 1979 Jan; 1(8108):119-22. PubMed ID: 84148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral disodium cromoglycate: alternative therapy of ulcerative rectocolitis].
    Cambri S; Tarantino G; Verre C
    Clin Ter; 1986 Oct; 119(2):127-31. PubMed ID: 3098494
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of cyclosporin with corticotropin for refractory ulcerative colitis.
    Okamura S; Aoki H; Ohashi S; Urano F; Shimodaira M; Kanamori S; Ishikawa H; Segawa K
    Hepatogastroenterology; 2003; 50(49):91-4. PubMed ID: 12629999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of exercise-induced asthma by three forms of sodium cromoglycate.
    Boner AL; Niero E; Grigolini C; Valletta EA; Biancotto R; Gaburro D
    Eur J Respir Dis; 1985 Jan; 66(1):21-4. PubMed ID: 3920066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the treatment of ulcerative colitis with the preparation Nalcrom (disodium cromoglycate)].
    Korczowski R; Nizankowska-Błaz T; Romańczuk W
    Wiad Lek; 1987 Mar; 40(6):372-5. PubMed ID: 3114961
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of sodium cromoglycate (SCG) in patients with food allergies.
    Basomba A; Campos A; Villalmanzo IG; Pelaez A
    Acta Allergol; 1977; Suppl 13():95-101. PubMed ID: 415503
    [No Abstract]   [Full Text] [Related]  

  • 18. [Failure of disodium cromoglycate in the treatment of 17 patients with chronic inflammatory diseases of the intestine. An occasion to review the pathogenetic problems of ulcerative rectocolitis and Crohn's disease].
    Franchi F; Meneghelli M; Seminara P; Spadini M; Bonomo R
    Minerva Dietol Gastroenterol; 1982; 28(4):285-91. PubMed ID: 6820127
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and tolerability of olsalazine (dipentum) in the treatment of patients with ulcerative colitis--results of a field study.
    Singer MV; Schmausser H; Schönfeld G
    Hepatogastroenterology; 2006; 53(69):317-21. PubMed ID: 16795963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM; Greenberg GR
    Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.